Resources

Abstracts Presented at the CRA Annual Scientific Meeting in Calgary, Alberta, February 26-March 1, 2025

This document is a guide to developing documents containing clinical guidance for the Canadian Rheumatology Association (CRA). It outlines the procedures required to receive CRA endorsement and the recommended overall approach for development. It is not meant to be a […]

The Canadian healthcare system is a complex patchwork of thirteen provincial and territorial systems for delivery of health services, alongside federal responsibility for a limited suite of health services...

JAK inhibitors (JAKi) are an effective treatment for several rheumatic conditions, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and juvenile idiopathic arthritis (JIA)...

The antimalarial drugs, chloroquine and especially hydroxychloroquine (HCQ), are essential drugs in the treatment of rheumatic diseases...

Abstracts Presented at the CRA Annual Scientific Meeting in Winnipeg, Manitoba, February 28-March 2, 2024

Biologic medications have become a cornerstone of the treatment for rheumatic diseases in adults and children in Canada. As more biologic options become available, including biosimilars, the ability of patients to access different biologic agents or switch between different formulations […]

Patients with autoimmune diseases such as systemic sclerosis (scleroderma) often have severe Raynaud’s phenomenon (RP) which may or may not be associated with digital ulcers. There are other diseases that may have severe RP as a manifestation such as but […]

Drug shortages and limited medication access due to cost have direct impacts on effective pharmacologic management of rheumatic diseases...

The Canadian Rheumatology Association (CRA) Workforce and Wellness surveys are periodically updated to monitor the Canadian rheumatology workforce characteristics.

Abstracts Presented at the CRA Annual Scientific Meeting in Quebec City, Quebec, February 8-11, 2023

A sustainable rheumatology workforce is essential to achieve the mission of the Canadian Rheumatology Association (CRA), Most importantly, a sustainable rheumatology workforce is necessary to meet Canada’s population health needs, and to address the priorities of better access, better health, […]